The document discusses the impact of co-morbidity in Employee Assistance Programs (EAPs) and emphasizes the need for enhanced identification and treatment of co-occurring substance use and mental disorders (CODs) to improve recovery outcomes. It reviews the historical evolution of EAPs, current challenges, and best practices for optimizing EAP effectiveness in addressing these issues. The importance of integrated assessments and evidence-based treatment approaches is highlighted to demonstrate value to employers and improve workplace productivity.